The effects of N-carbamylglutamate (NCG) on the growth performance, tissue development, and blood parameters of broilers are unknown. In this study, 2 linked experiments were conducted to investigate the effects of 4 graded dietary levels and 3 dietary stages of NCG in a Chinese indigenous yellowfeather broiler breed during 2 growth phases: 1 to 18 d and 19 to 36 d. The dietary levels of NCG were 0.05%, 0.10%, 0.15%, and 0.20%, and dietary stages were designed to add NCG during the starter stage or grower stage or throughout the experimental period. At the age of 18 d, graded doses of NCG from 0.05 to 0.20% in the diet produced quadratic (P < 0.05) positive responses in body weight, width of intermuscular fat cingulum, liver weight, serum blood urea nitrogen, and serum lowdensity lipoprotein as well as linear (P < 0.05) positive responses in albumin serum concentration. The average feed per gain and mortality were unaffected by dietary NCG levels. Among 3 dietary treatments, only NCG dietary treatments throughout the experimental period improved the body weight and daily weight gain linearly (P < 0.05). The daily weight gain under the 3 dietary treatments used indicated that the most fitting dose is 0.1% NCG among the 4 dietary levels of NCG (P < 0.05). At this dose, muscle weight increased, whereas subcutaneous adipose as well as the serum contents of uric acid, triglyceride, and albumin decreased. Considering the growth performance and tissue development under the conditions used in this study, the best-fit model for NCG requirements of Chinese yellowfeather broilers was estimated from regression analysis to be 0.09 to 0.12% dietary NCG treatments during the grower stage. The modified blood parameters indicated that NCG dietary effects on broiler growth may be accompanied by modified homeostasis of arginine metabolism, lipid deposition, protein synthesis, and immune response.
INTRODUCTION
In poultry, arginine is one of the nutritionally essential amino acids. However, indiscriminate exogenous addition of arginine in diet can affect the absorption balance of alkaline amino acids such as lysine. So, regulating endogenous arginine synthesis to increase the supply of arginine is an economic and effective strategy in poultry breeding. N-carbamylglutamate (NCG) is a structural analogue of N-acetylglutamate (NAG), which is an endogenous essential cofactor of carbamyl phosphate synthetase-1 (CPS1) of the arginine-C 2019 Poultry Science Association Inc. Received June 28, 2018. Accepted January 17, 2019. 1 Corresponding author: ssr236@163.com synthetic pathway and can improve endogenous synthesis of arginine (Wu et al., 2004; Frank et al., 2007) . NCG treatments have been shown to increase the growth rate and muscle development in mammals (Frank et al., 2007; Ye et al., 2017) . Compared with NAG, NCG is more stable and not easy to degrade in the body (Wu et al., 2015) , and accompanied by a lower price than NAG or arginine. Currently, NCG is used as a promising feed additive in the farm livestock industry in many countries, especially China (Wu et al., 2015) . However, no data are available regarding the effect of NCG on the growth performance of broilers.
Studies have shown that NCG treatments can stimulate citrulline and arginine synthesis in enterocytes and increase the endogenous synthesis of arginine (Frank et al., 2007; Zeng et al., 2012; Ye et al., 2017) . Arginine, 2241 a nutritionally essential amino acid in vertebrates, has garnered much interest because of its powerful physiologic properties and pharmacological role in developmental and health problems (Wu et al., 2009) . It has been reported that dietary arginine supplementation has an active impact on broiler growth and organ development (Ruiz-Feria et al., 2001; Ebrahimi et al., 2014; Jahanian and Khalifeh-Gholi, 2018) . Furthermore, in addition to arginine metabolism, protein synthesis (Ye et al., 2017) and lipid metabolism (Sun et al., 2017; Ye et al., 2017) may be involved in the NCG dietary effects on humans and other mammals. Presumably, dietary NCG supplementation in broilers can modify the levels of arginine, protein, and lipid metabolites in serum fluids, thereby improving the growth performance and development of tissues.
The objectives of this study were to investigate the effects of dietary supplementation of NCG with different levels and different feeding stages on the growth performance of Chinese indigenous yellow-feather broiler cocks and to explore whether exposure to NCG affected tissue development.
MATERIALS AND METHODS

Birds and Experimental Design
This study was conducted at the Poultry Institute, Chinese Academy of Agricultural Sciences (Yangzhou, 32 • 31 17.56 North, 119
• 30 30.97 East, 6.4 m above sea level), from December 2016 to January 2017. This study was conducted according to the guidelines of the Animal Ethics Committee of the Academy of Chinese Agricultural Science.
A total of 2 linked experiments were conducted to determine the NCG requirement during 2 growth stages of Xueshan yellow-feather broiler cocks (a Chinese indigenous crossbred broiler of medium-growing meat-type strains obtained from Jiangsu Lihua Animal Husbandry Co., LTD, Changzhou, China). Experiment 1 examined the starter stage (day 1 to 18, initial BW 39.31±0.15 g) and experiment 2 assessed the grower stage (day 19 to 36). Birds were provided with continuous light. The feeding room temperature was set at 35
• C for the first 3 d, after which it was reduced by 3
• C each week until it reached 20
• C, where it was maintained until the end of the 36-d experiment. The RH of the feeding room was maintained between 40% and 50% in Experiments 1 and 2. Birds were provided ad libitum access to water and diets under the same standard conditions throughout the entire experimental period.
Experimental Diet and Groups
The basal corn-soybean meal pellet diet for each experiment (Arginine 1.22% to 1.34%, without NCG; Table 1 ) was based on the recommendations of the Chinese Feeding Standard of yellow-feather broiler (2004) and was the feed used for dietary treatment 1 (controls, abbreviated as Con) in each experiment. Dietary treatment 2 to 5 consisted of the basal diet supplemented with 0.05% (abbreviated as N1), 0.10% (abbreviated as N2), 0.15% (abbreviated as N3), and 0.20% (abbreviated as N4) NCG (purity 80%, a gift from Dr. Xin Wu at the Institute of Subtropical Agriculture, Chinese Academy of Sciences, Changsha, China), respectively. The NCG dietary treatments were added in 3 ways as 1) during the starter stage, 2) during the grower stage, or 3) throughout the entire experimental period. Experiment 1 was conducted with a single factorial arrangement of 5 dietary treatments (Con, N1, N2, N3, and N4). In the second experiment, the control group (25 replicates, 20 cocks/replicate) of experiment 1 had been divided into 5 subgroups, which were subjected, respectively, to the basal diet (Con-Con) and 4 NCG dietary treatments (Con-N1, Con-N2, Con-N3, and Con-N4). Simultaneously, dietary treatment 2 to 5 groups (10 replicates, 20 cocks/replicate, respectively) in experiment 1 were divided, respectively, into 2 subgroups, and these subgroups were subjected to either basal diets or corresponding dietary treatments (N1-Con/N1-N1, N2-Con/N2-N2, N3-Con/N3-N3, N4-Con/N4-N4). Removing the birds used for sampling and elimination in experiment 1, each of the aforementioned subgroups in experiments 2 was placed in 5 replicate wire-caged pens (1.2 m × 0.8 m × 0.6 m) containing 15 birds.
Sampling and Measurements
Growth performance, including the body weight of chicks, feed consumption, and mortality, was recorded at the ages of 18 and 36 d. Concurrently, 1 cock per replicate from each group in experiment 1 were selected and used for follow-up sampling and checks. In experiment 2, only the groups with differences in growth compared with the control group were selected, and 2 cocks per replicate in these groups were used for followup sampling and checks. Blood (approximately 2 mL) of cocks from each group was collected via the vena brachialis and placed into tubes containing EDTA-Na 2 (an anticoagulant) for the subsequent determination of the blood parameters, including total protein (TP), albumin (ALB), globulin (GLO), blood urea nitrogen (BUN), uric acid (UA), glucose (GLU), total cholesterol (Tch), triglyceride (TG), high-density lipoprotein (HDL), and low-density lipoprotein (LDL) . These blood parameters were tested using an aeroset (USA, Abbott, C-8000) within 2 h after collection. Birds were euthanized by cervical dislocation after blood collection, which is considered to be acceptable for euthanasia of birds according to the American Veterinary Medical Association (AVMA) Guidelines for the Euthanasia of Animals: 2013 Edition.
After cocks were euthanized, the width of the intermuscular fat cingulum (IFC; part of the abdominal subcutaneous fat located at the end of the xiphoid process near the margin of pectoralis major) was mea- 
Statistical Analysis
Statistical analyses were carried out with SPSS 22.0 for Windows (SPSS Inc., Chicago, IL). Differences in NCG diet supplementation were tested using 1-way analysis of variance (ANOVA) for independent samples. Univariate analysis of the general linear model was used to test the main effects of one of the NCG doses at 3 different stages and to investigate their interactive effects in experiment 2. Regression of estimation curves were used to compare the best-fit quadratic and linear models for these objective traits. All data are presented as the mean with pooled SEM values. A P-value less than 0.05 is considered significant.
RESULTS
Growth Performance
In experiment 1, no significant effect (P > 0.05) of adding NCG to diets was found regarding body weight of broilers at 18 d nor for daily weight gain, feed per gain, and mortality of broilers from 1 to 18 d (Table 2, shown as P-NCG). However, a modest quadratic response to increasing dietary NCG was obtained for body weight (P = 0.064) and daily weight gain (P = 0.062) of broilers, indicating that maximal performance required 0.10% NCG (compared with the control group, P = 0.019 and 0.037, respectively).
In experiment 2, except feed per gain (P = 0.014) broilers body weight at 36 d, daily weight gain and mortality from 19 to 36 d were not affected by NCG (P > 0.05) ( Table 3, (Table 3) . Among the doses of NCG dietary treatments, the results of daily weight gain and feed per gain indicated that the optimal performance required 0.10% NCG (P = 0.025) and 0.20% NCG (P < 0.001), respectively. A modest quadratic response to increasing dietary NCG during the grower stage was observed for body weight (P = 0.068) and daily weight gain (P = 0.085), indicating that maximal performance required 0.10% NCG (compared with the control group, P = 0.055 and 0.032, respectively). Feed per gain was Notes: In the same line, superscript * indicates a significant difference at the 0.05 level between the control group and the other dietary treatments group, and the values with the same letter are not significantly different for all possible combinations of these different groups (P > 0.05), and values with different letters are significantly different for all possible combinations of these different groups (P < 0.05 or P < 0.01). Superscript 1 : Feed per gain (percent of the average daily feed intake relative to the daily weight gain) Note: In the same column, superscript * indicates a significant difference at the 0.05 level between the control group and the other dietary treatments group, the values with the same letter are not significantly different for all possible combinations of these different groups (P > 0.05), and values with different letters are significantly different for all possible combinations of these different groups (P < 0.05 or P < 0.01). Superscript 1 to 4 : The P-values indicate a significant difference by univariate analysis of the general linear model between the control group and the other dietary treatments group of the one of NCG doses (N1, N2, N3, or N4), including Con-Con, Nn-Con, Con-Nn, and Nn-Nn (n = 1 to 4). Superscript 5 : The total P-values indicate a significant difference of all of the groups. Superscript 6 : Feed per gain (percent of the average daily feed intake relative to the daily weight gain).
influenced the response to increasing dietary NCG during the starter stage (P = 0.027). Compared to the control group, N2 dietary treatment during the starter stage increased feed per gain (P = 0.028) and N1 dietary treatment throughout the experimental period decreased feed per gain (P = 0.013).
Tissue Development
In experiment 1, there was no significant effect (P > 0.05) of adding NCG to diets on width of IFC, spleen weight, PM weight, LM weight, and their index of broilers at 18 d except for body weight (P < 0.001) and liver weight (P = 0.046) ( Table 4 , shown as P-NCG). Body weight of chickens at 18 d increased quadratically (P < 0.001) in response to increasing dietary NCG, and maximal body weight was obtained with 0.10% NCG (P < 0.001). Width of IFC (P = 0.038) and liver weight (P = 0.032) of chickens at 18 d increased quadratically in response to increasing dietary NCG, and maximal width of IFC and maximal liver weight were obtained with 0.10% NCG (compared with 2 , and Y = 1.13 + 1.88X − 8.75X 2 , respectively, indicating that 0.12%, 0.12%, 0.08%, and 0.11% NCG was required for the optimal properties of the 3 treatments.
In experiment 2, significant effects of adding NCG to diets were found for body weight (P = 0.021), width of IFC (P = 0.001), spleen weight (P = 0.012), PM weight (P = 0.024), spleen index (P = 0.012), and LM index (P = 0.048) of 36-day-old broilers (Table 5, (Table 5) . Moreover, NCG dietary treatment had quadratic significant effects on body weight (P = 0.017, quadratic model: Y = 767.43 + 879.88X − 4937.50X 2 , estimated optimal dose required 0.09% NCG). Among the doses of dietary treatments, body weight and PM weight under the conditions used here indicated that the fit dose was 0.10% NCG (P = 0.002 and 0.041). Compared to the control group, N1 dietary treatment during the grower stage increased the spleen index (P = 0.013). Furthermore, N2 dietary treatment during the grower stage increased body weight (P = 0.003), PM weight (P = 0.054), and LM weight (P = 0.024). Finally, N2 dietary treatment throughout the experimental period increased body weight (P > 0.003), and N3 dietary treatment during the grower stage decreased width of IFC (P < 0.001).
Blood Biochemical Analyses
In experiment 1, there were no significant effects (P > 0.05) of dietary NCG on TP, ALB, GLO, A/G, UA, GLU, Tch, TG, HDL, and LDL in serum of broilers at 18 d; however, there was a significant effect on BUN (P < 0.001; Table 6 , shown as P-NCG). The serum concentrations of ALB increased linearly (P = 0.033, linear model: Y = 11.31 + 3.65X) in response to increasing dietary NCG, and maximum ALB was obtained with 0.20% NCG (compared with the control group, P = 0.017). The contents of BUN (P < 0.001) and LDL (P = 0.053) increased quadratically in response to increasing dietary NCG. In comparison with the control group, increased BUN was obtained with 0.10% (P < 0.001) and 0.15% NCG (P < 0.001) and increased LDL was obtained with 0.15% NCG (P = 0.035). BUN and LDL contents were both estimated to be the highest at 0.11% NCG according to quadratic models Y = 1.28 + 25.67X − 121. In experiment 2, there were no significant effects (P > 0.05) of dietary NCG on TP, ALB, GLO, A/G, BUN, GLU, Tch, TG, HDL, and LDL in serum of 36-day-old broilers; however, there were significant effects on UA (P = 0.046) and TG (P = 0.049; Table 6 , shown as Total P-NCG). Among the dietary treatment stages, NCG dietary treatments during the grower stage had significant effects on serum concentrations of ALB (P = 0.048) and TG (P = 0.039), which decreased linearly (P = 0.062 and 0.008, linear model: Y = 12.69 − 8.59X and Y = 1.14 − 2.84X, respectively) in response to increasing dietary NCG. Moreover, minimal ALB The total P-values indicate a significant difference of all of the groups.
was obtained with 0.10% (compared with the control group, P = 0.047), and minimal TG was obtained with 0.10% (compared with the control group, P = 0.053) and 0.15% NCG (compared with the control group, P = 0.023). Among the doses of NCG dietary treatments, UA serum data indicated that the fit dose was 0.10% NCG (P = 0.029). Compared with the control group, N2 dietary treatment throughout the overall experimental period decreased serum TG (P = 0.051) Table 7 .
DISCUSSION
As previously noted, there is a need to thoroughly assess the requirements of modern broiler chickens for dietary NCG. The results presented that dietary NCG supplementation could enhance growth rate of broilers, whose effect is consistent on pigs (Frank et al., 2007; Yang et al., 2013; Ye et al., 2017) . It has been confirmed that NCG is a non-toxic substance with no genotoxicity (Wu et al., 2015) . The tolerated dose of NCG in animals is up to 0.50% (Wu et al., 2015) . In this study, there was no difference in the effects of 0.10%, 0.15%, and 0.20% NCG dietary supplementation from 19 to 36 d or from 1 to 36 d on body weight, indicating that a relatively lower level of NCG dietary treatments is able to improve growth performance. Similar to previous studies in mice (Wu et al., 2015) , pigs (Zhang et al., 2014) , and cows (Chacher et al., 2014) , the effects of NCG on the growth and development of animals were quadratic and not in a dose-dependent manner. NCG can increase endogenous arginine synthesis and plasma concentrations of arginine (Wu et al., 2004; Frank et al., 2007) . The comparative experiments of NCG and arginine in mammals demonstrated that both of them play a relatively homogenous role in animal growth (Wu et al., 2010; Zhang et al., 2016a Zhang et al., , 2016b and reproduction (Liu et al., 2012; Zhang et al., 2016a; Sun et al., 2017) . Interestingly, the phenomenon same as NCG in broilers is also observed in experiments on increasing arginine supplementation in broiler chickens (Jahanian, 2009; Fouad et al., 2013; Ebrahimi et al., 2014; Jahanian and Khalifeh-Gholi, 2018) , arginine supplementation at the intermediate level improved growth performance, and confirmed that the effects of exogenous arginine on the growth and development of birds were also quadratic and not in a dose-dependent manner. It was suggested that whether through endogenous NCG synthesis or intestinal absorption, the amount of arginine playing a physiological role in body growth is limited.
NCG dietary treatment had a significant effect on the feed per gain of yellow-feather broilers from 19 to 36 d, influencing the response to increasing dietary NCG during the starter stage, and among the doses of NCG dietary treatments in the presented study, the data indicated that optimal performance required 0.20% NCG. In addition, 0.10% NCG diet during the starter stage could increase feed per gain, but 0.05% NCG diet throughout the experimental period could Table 7 . Effects of dietary NCG supplementation on serum biochemical indices of yellow-feather broilers at the age of 36 d in experiment 2. Note: In the same line, superscript * indicates a significant difference at the 0.05 level between the control group and the other dietary treatments group, and superscript * * indicates a significant difference at the 0.001 level between the control group and the other dietary treatments group. The values with the same letter are not significantly different for all possible combinations of these different groups (P > 0.05), and values with different letters are significantly different for all possible combinations of these different groups (P < 0.05 or P < 0.01). Superscript 1 : the P-values indicate a significant difference by univariate analysis of the general linear model between the control group and the other dietary treatments group of the N2 dose, including Con-Con, Con-N2, N2-Con, and N2-N2. Superscript 2 : the total P-values indicate a significant difference of all of the groups.
decrease feed per gain. However, previous studies have confirmed that the effects of NCG dietary treatments on the feed per gain in mammals differed. Dietary NCG levels did not influence feed per gain in mice, except that 0.10% NCG during the starter stage decreased feed conversion ratio (Wu et al., 2015) . Dietary 0.10% NCG enhanced the efficiency of feed use in weaned Huanjiang mini-pig piglets . Furthermore, feed efficiency was either improved in male during the starter stage (Jahanian, 2009) , and in female Ross broilers during entire growth period (Ebrahimi et al., 2014) , or not affected in Cobb broilers during the grower stage (Fouad et al., 2013) by dietary arginine levels. Presumably, NCG dietary treatments in broilers may interact with the regulatory components involved in different breeds, development stages, and length of feeding time, showing different effects of the feed intake and efficiency. Considered both the growth performance and feeding cost, the fit model for the NCG requirements of yellow-feather broilers were estimated to be a relatively lower NCG supplementation during the grower stage. There is abundant evidence that NCG supplementation in mammals have positive physiological effects on health (Wu et al., 2010; Cao et al., 2016; Zhang et al., 2016a) , growth (Wu et al., 2010; Zhang et al., 2016a Zhang et al., , 2016b , and reproduction (Liu et al., 2012; Zhang et al., 2016a; Sun et al., 2017) , as well as play important roles in ameliorating vascular function, influencing endocrine status, improving the tissue antioxidation capability, and promoting organ development. Similarly, these results demonstrated that oral NCG supplementation in broiler cocks promoted growth, accompanied by increasing LM weight, liver weight, and width of IFC at the end of the starter period. NCG supplementation also increased PM weight, LM weight, spleen index, and LM index and decreased the width of IFC at 36 d. Furthermore, arginine supplementation has been confirmed to improve the production performance of broiler chickens during the starter period (Jahanian, 2009; DeGroot et al., 2018) , during the grower period (Fouad et al., 2013) or throughout the whole feeding period (Ebrahimi et al., 2014; Jahanian and KhalifehGholi, 2018) , and to specifically targets muscle (Jahanian, 2009; Ebrahimi et al., 2014; DeGroot et al., 2018) , fat (Fouad et al., 2013; Ebrahimi et al., 2014) , and immune organ (Jahanian, 2009; Jahanian and KhalifehGholi, 2018) development. Supplementation of NCG showed beneficial effects on the production performance and organ development of broiler chickens, which requires arginine.
It has been verified that NCG administration activates a key enzyme (CPS1) of the arginine-synthetic pathway, which stimulates citrulline and arginine synthesis in enterocytes (Wu et al., 2004; Wu et al., 2010) . NCG is clinically used to treat NAG synthase and CPS1 deficiency, organic acidurias, and maple syrup urine disease (Ah et al., 2014; Burlina et al., 2016) . Furthermore, dietary NCG has been postulated to play an important role in the programming of the growth performance and organ development in mammals, which are associated with complex metabolic pathways (Frank et al., 2007; Zeng et al., 2012; Chacher et al., 2014; Sun et al., 2017) ; however, studies in avian species are scarce. Meanwhile, the beneficial effect of dietary arginine supplementation on broiler growth is associated with modulation of the protein (Corzo et al., 2003; Ebrahimi et al., 2014) and lipid (Fouad et al., 2013; Ebrahimi et al., 2014) metabolic and immune response (Jahanian, 2009; Jahanian and Khalifeh-Gholi, 2018) networks. Similar to previous studies in arginine treated chicks, this study provides the first evidence for the presence of modified BUN (increased in the end of starter stage) and UA (decreased in the end of grower stage) in the serum of NCG treated broiler cocks, which correspond to modulated arginine metabolism and increased muscle and protein gain. Moreover, it is noteworthy that serum concentrations of ALB and LDP were increased at the end of the starter stage with reduced serum ALB and TG concentrations at the end of grower stage in these NCG treated broiler cocks. Previous studies in chickens and mammals after arginine supplementation demonstrated that decreased TG concentrations (Fouad et al., 2013; Ebrahimi et al., 2014) and elevated ALB concentrations (Deng et al., 2005; Emadi et al., 2011; Szabo et al., 2014) corresponded to reduced subcutaneous fat deposition by modulating lipid metabolism and modified immune organ indices by modulating systemic immune response.
It is interesting that the effects of NCG on muscle weight and indices, abdominal subcutaneous fat, immune organ indices, and related serum biochemical indices in broilers behaved linearly and had a dose dependent relationship, but compared with the control group, these performances were significantly modified by a relatively lower level of NCG dietary treatment. Therefore, it was suggested that a relatively lower level of NCG dietary treatment may more effectively improve body weight, increase muscle index, and decrease subcutaneous fat accretion.
In summary, this study provides the first evidence that dietary NCG has a positive effect on growth performance, tissue development and blood parameters of broiler chickens. Regarding production and organ weights, NCG supplementation should be recommended in the grower phase of broilers. Moreover, the best-fit model for the NCG requirements of Chinese yellow-feather broilers for optimal weight gain and feeding expenditure were estimated from regression analysis to be 0.09% to 0.12% dietary NCG.
